Navigation Links
Hope For Patient With Alzheimer’s Diseas

New research shows combining the drugs memantine and donepezil may improve memory in patients with Alzheimer’s disease. //

Researchers studied more than 300 patients with moderate to severe Alzheimer’s. Participants were already taking the drug donepezil when the study began. Donepezil works by preventing the breakdown of acetylcholine, a chemical messenger in the brain that is important for memory and other thinking skills.For the study, patients received either memantine or a placebo. Memantine targets glutamate, a brain chemical that is associated with nerve cell death when produced in high quantities. The Food and Drug Administration approved memantine in October 2003.

Researchers found patients who took memantine and donepezil experienced significant improvement in cognition, memory, and overall daily functioning compared to those in the placebo group. Researchers say they were pleasantly surprised to see that the two drugs worked well together. Memantine is significant, since it provides an entirely new medication option for the 2.5 million people currently suffering at the advanced stage of Alzheimer’s.

Prior to the FDA’s approval of memantine, only acetylcholinesterase inhibitors, like donepezil, were approved for treating Alzheimer’s patients. Researchers say the study is significant because this is the first time combining two Alzheimer’s drugs has shown positive results.

Researchers conclude saying , “ To find a new medication that can provide substantial benefit to patients at this stage of the disease, either alone or in combination with another Alzheimer’s drug, is certainly good news ... While memantine is not a cure for Alzheimer’s, if it helps to keep a person with Alzheimer’s at home for six months or one year longer, then it is a victoy.”

Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... ... athletic programs, launches new Wimbledon Athletics Facebook page to educate the ... for unsuspected cardiac abnormalities. About 2,000 people under the age of 25 die ...
(Date:11/25/2015)... IL (PRWEB) , ... November 25, 2015 , ... On ... assets of Tri Lite’s personal heating products business. Cozy Products explains what ... personal heaters that fit in well with the Cozy Products business model: to sell ...
(Date:11/25/2015)... ... 25, 2015 , ... SCOTTSDALE, AZ) - Today, Dr. ... both surgical and non-surgical treatments, announced the expansion of his private practice capabilities ... , Highly trained and nationally recognized for his natural approach, Dr. Todd ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, ... friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, ... , For 65 years, Brillianteen has been a treasured tradition for numerous families ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a ... “I thought there had to be a convenient and comfortable way to protect them ... enables disabled individuals to safely travel during cold or inclement weather. In doing so, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... UTRECHT , Nederland, November 26, 2015 ... --> Een nieuwe aanpak combineert ... van gevorderde kanker. ... -->      (Photo: ... van het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... , November 26, 2015 3D bioprinting ... 2022, according to a new report by Grand View Research ... Disease (CKD) which demands kidney transplantation is expected to boost ... effective substitute for organ transplantation. --> 3D bioprinting ... 2022, according to a new report by Grand View Research ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology: